Infinity Pharmaceuticals, Inc. Cash and Cash Equivalents
Infinity Pharmaceuticals, Inc. had Cash and Cash Equivalents of $17.75 million as of 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2023-08-10
- 2023-06-30: Cash and Cash Equivalents, at Carrying Value $17.75M.
- 2023-03-31: Cash and Cash Equivalents, at Carrying Value $25.74M.
- 2022-12-31: Cash and Cash Equivalents, at Carrying Value $38.31M.
- 2022-09-30: Cash and Cash Equivalents, at Carrying Value $47.18M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2023-06-30 | $17.75M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $25.74M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $38.31M 10-Q · filed 2023-08-10 | |
| 2022-09-30 | $47.18M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $45.84M 10-Q · filed 2023-08-10 | |
| 2022-03-31 | $53.13M 10-Q · filed 2023-05-09 | |
| 2021-12-31 | $80.73M 10-K · filed 2023-03-28 | |
| 2021-09-30 | $90.09M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $97.26M 10-Q · filed 2022-08-09 | |
| 2021-03-31 | $106.76M 10-Q · filed 2022-05-03 | |
| 2020-12-31 | $28.59M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $18.53M 10-Q · filed 2021-11-02 | |
| 2020-06-30 | $28.92M 10-Q · filed 2021-07-27 | |
| 2020-03-31 | $30.48M 10-Q · filed 2021-05-13 | |
| 2019-12-31 | $22.26M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $21.59M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $42.63M 10-Q · filed 2020-07-30 | |
| 2019-03-31 | $52.95M 10-Q · filed 2020-05-11 | |
| 2018-12-31 | $48.62M 10-K · filed 2020-03-03 | |
| 2018-09-30 | $32.22M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $49.16M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $30.57M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $34.61M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $33.58M 10-Q · filed 2018-11-05 | |
| 2017-06-30 | $66.20M 10-Q · filed 2018-08-07 | |
| 2017-03-31 | $75.43M 10-Q · filed 2018-05-08 | |
| 2016-12-31 | $74.06M 10-K · filed 2019-03-14 | |
| 2016-09-30 | $98.51M 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $122.35M 10-Q · filed 2017-08-03 | |
| 2016-03-31 | $113.75M 10-Q · filed 2017-05-09 | |
| 2015-12-31 | $188.17M 10-K · filed 2018-03-15 | |
| 2015-09-30 | $137.28M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $134.61M 10-Q · filed 2016-08-09 | |
| 2015-03-31 | $223.04M 10-Q · filed 2016-05-04 | |
| 2014-12-31 | $307.40M 10-K · filed 2018-03-15 | |
| 2014-09-30 | $321.26M 10-Q · filed 2015-11-05 | |
| 2014-06-30 | $85.52M 10-Q · filed 2015-08-06 | |
| 2014-03-31 | $54.97M 10-Q · filed 2015-05-06 | |
| 2013-12-31 | $68.11M 10-K · filed 2017-03-14 | |
| 2013-09-30 | $53.48M 10-Q · filed 2014-11-10 | |
| 2013-06-30 | $55.25M 10-Q · filed 2014-08-11 | |
| 2013-03-31 | $101.14M 10-Q · filed 2014-05-06 | |
| 2012-12-31 | $175.74M 10-K · filed 2016-02-23 | |
| 2012-09-30 | $52.92M 10-Q · filed 2013-11-07 | |
| 2012-06-30 | $19.65M 10-Q · filed 2013-08-08 | |
| 2012-03-31 | $23.46M 10-Q · filed 2013-05-07 | |
| 2011-12-31 | $24.20M 10-K · filed 2015-02-24 | $24.20M 10-K · filed 2012-03-13 |
| 2011-09-30 | $23.09M 10-Q · filed 2012-11-06 | $23.09M 10-Q · filed 2011-11-08 |
| 2011-06-30 | $17.46M 10-Q · filed 2012-08-07 | $17.46M 10-Q · filed 2011-08-09 |
| 2011-03-31 | $21.72M 10-Q · filed 2012-05-08 | |
| 2010-12-31 | $20.42M 10-K · filed 2014-02-25 | $20.42M 10-Q · filed 2011-08-09 |
| 2010-09-30 | $18.18M 10-Q · filed 2011-11-08 | |
| 2010-06-30 | $24.44M 10-Q · filed 2011-08-09 | |
| 2009-12-31 | $16.29M 10-K · filed 2013-03-05 | $16.29M 10-Q · filed 2011-08-09 |
| 2008-12-31 | $16.57M 10-K · filed 2012-03-13 |